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ABSTRACT 
Objective: This study was undertaken to investigate the role of 
tumor necrosis factor-a (TNF-CY) in discriminating between 
uncomplicated parapneumonic effusion (UCPPE) and compli- 
cated parapneumonic effusion (CPPE). 
Method: Using a commercially available high sensitivity enzyme- 
linked immunosorbent assay (ELISA) kit, concentrations of TNF 
were measured in the serum (TNFs) and pleural fluid (TNFpf) 
of 21 patients with parapneumonic effusion (PPE), 13 patients 
with UCPPE, and 8 patients with nonempyemic CPPE. 
Results: No significant difference in values of TNF concentra- 
tion was found between the group with UCPPE and that with 
CPPE (P > 0.05). Concentration levels of TNFpf were signifi- 
cantly higher in the group with CPPE than in that with UCPPE 
(P = 0.0008). Levels of TNF in pleural fluid were significantly 
higher than in serum in both groups (P < 0.001). The ratio of 
TNF in pleural fluid to that in serum (TNFr) was significantly 
higher in the CPPE group than in the UCPPE group (P = 
0.0002). At an optimal cutoff point of 10.7 pg/mL for TNFpf, 
the sensitivity was 87.5%, specificity was 92.3%, positive pre- 
dictive value was 87.5%, negative predictive value was 93.3%, 
and total accuracy was 90.5% (P < 0.001). At an optimal cut- 
off point of 3.0 for TNFr, all values were 100% (P < 0.00001). 
Conclusions: The results of this study indicate that TNFpf, and 
particularly TNFr, may be helpful in discriminating between 
UCPPE and CPPE. However, further studies are needed in a 
larger population to confirm these findings. 
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A parapneumonic effusion (PPE) is an accumulation of 
exudative pleural fluid associated with an ipsilateral 
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pulmonary infection. Parapneumonic effusions are prob- 
ably the most common exudative pleural effusions; 
approximately 40% of patients with bacterial pneumonia 
have an accompanying pleural effusion.’ These effusions 
may also accompany lung abscess and bronchiectasis. 
Parapneumonic effusions can be classified into 
uncomplicated, complicated, or empyema, based on the 
characteristics of a diagnostic thoracentesis. Uncompli- 
cated PPEs (UCPPEs) are not infected, have a pH greater 
than 7.30, a glucose level greater than 60 mg/dL, and a 
lactate dehydrogenase (LDH) level less than 1000 IU/L. 
They usually can be managed by systemic antibiotics, and 
usually do not need tube thoracostomy. Complicated PPEs 
(CPPEs) usually are infected, have a pH less than 7.10, a 
glucose level less than 40 mg/dL, and an LDH level greater 
than 1000 IU/L. Complicated PPEs are initially thin and 
serous, but become more purulent as disease progresses. 
An infected effusion is called an empyema when the effu- 
sion becomes thick and turbid (pus). Both CPPE and 
empyema require tube thoracostomy.2*3 These three cat- 
egories of PPE are not sharply defined but rather repre- 
sent a continuous spectrum.* 
The use of early markers for the transformation of 
UCPPE to CPPE or empyema remains controversial.5,6 For 
instance, if intrapleural pus is detected or the Gram stain 
of the pleural fluid is positive, tube thoracostomy is indi- 
cated. Because the diagnostic sensitivities of these fmd- 
ings are low,’ determination of pleural fluid pH, glucose, 
and LDH are recommended to assist in the decision to 
drain PPEs. However, no general consensus exists regard- 
ing the clinical usefulness of these criteria.6as In a recent 
meta-analysis study,8 pH measurement was found to be 
superior to glucose and LDH measurements in predicting 
CPPEsYet most reports describe a midrange of indeter- 
minate pleural fluid pH value, often placed between 7.10 
and 7.30, that does not reliably discriminate between 
CPPEs and UCPPEs.‘s9 
Tumor necrosis factor-a (TNF-o) is a key cytokine in 
inflammatory reactions. It is synthesized by various acti- 
vated phagocytic and nonphagocytic cells, and a wide 
variety of infectious or inflammatory stimuli are capable 
of triggering TNF biosynthesis.10x11 High levels of this 
cytokine in pleural fluid have been detected in several dis- 
eases that cause pleural effusion, including CPPE and 
UCPPE.12-14 However, the clinical usefulness of pleural 
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fluid TNF (TNFpf) concentrations or pleural fluidserum 
TNF ratio (TNFr) for discrimination between CPPEs and 
UCPPEs has not previously been reported. 
The aim of this study is to investigate the diagnostic 
usefulness of TNFpf and TNFr in discriminating between 
UCPPEs and CPPEs. 
PATIENTS AND METHODS 
The study population consisted of 21 patients with PPE, 
13 patients (7 males; 6 females) aged 56 to 91 years were 
with UCPPE, and 8 patients (5 males; 3 females) aged 50 
to 92 years were with CPPE that was not empyemic. Effu- 
sions were considered UCPPE when there was an acute 
febrile illness with purulent sputum, pulmonary infiltrate, 
and responsiveness to antibiotic treatment, in the absence 
of other diseases causing pleural effusion, and with no 
direct or indirect evidence of bacterial invasion of the 
effusion. Complicated PPE was considered in the pres- 
ence of pneumonia confirmed clinically and radiograph- 
ically in the absence of other diseases causing pleural 
effusion, with one or more of the following indicators of 
bacterial invasion of the effusion: bacteria in Gram smear 
or culture, and pH less than 7.10. 
Pleural fluid samples were obtained by intercostal 
needle aspiration. Samples of pleural fluid and periph- 
eral venous blood were obtained within 15 minutes of 
one another for LDH, glucose, pH, white blood cell count 
(WBC), and TNF analysis. All pleural fluids were cultured 
and stained by Gram stain for the presence of bacteria, 
and analyzed cytologically for the presence of tumor cells. 
All patients with CPPE were treated with chest tube 
drainage. The study met the criteria of the Ethics Com- 
mittee of the Bnai Zion Medical Center, Haifa, Israel. 
timor Necrosis Factor Assay 
Samples of pleural fluid and peripheral venous blood 
(after clotting) were centrifuged at 2500 rpm, at 4°C cen- 
trifuge temperature for 10 minutes. The supernatants 
were stored at -70°C until TNF assay Tumor necrosis fac- 
tor concentrations were measured using commercially 
available (Quantikine HS, R&D Systems, Minneapolis, MN), 
solid phase high sensitivity enzyme-linked immunosor- 
bent assay (ELISA), according to the manufacturers rec- 
ommendation. Results were expressed in picograms per 
milliliter; the detection limit was 0.18 pg/mL. 
Statistical Analysis 
Data were expressed as mean + standard deviation (SD) 
values, and 95% confidence intervals (CIs) for means, 
and proportions were calculated. The nonparametric 
Mann-Whitney U test was used to compare between the 
means of TNF values of the two groups. Receiver oper- 
ating characteristic (ROC) analysis was performed to 
detect the best cutoff point (that with the highest accu- 
racy) of TNFpf and TNFr values, to discriminate between 
groups. Sensitivity of the optimal cutoff point is defined 
as the probability that a patient with a CPPE will have 
a TNF value above the optimal cutoff point (sensitivity 
= [true positive (TP)/TP + false negative 01). Speci- 
ficity of the optimal cutoff point is defined as the prob- 
ability that a patient with an UCPPE will have a TNF 
value below the optimal cutoff point (specificity = [true 
negative (TN)/TN + false positive (FP)]). Positive pre- 
dictive value (PPV) of the optimal cutoff point is defined 
as the probability that a patient with a TNF value above 
the optimal cutoff point has a CPPE (PPV = [TP/TP + 
FP]). Negative predictive value (NPV) of the optimal cut- 
off point is defined as the probability that a patient with 
a TNF value below the optimal cutoff point does not 
have a CPPE (NPV = [TN/TN + FNI). Total accuracy of 
the optimal cutoff point refers to the extent that the 
TNF value measures the true value of what is under 
study (total accuracy = [TP + TN/TP + FP + TN + FN]). 
The association between categoric variables achieved 
by the ROC analysis was estimated using the chi-square 
test. Two-tail P-values of 0.05 or less were considered 
significant. 
RESULTS 
Mean age of the UCPPE group was 71 + 12 years, and of 
the CPPE group was 68 + 20 years. No significant differ- 
ence was found between the two groups. All patients in 
the CPPE group had a pH value below 7.10. Four of them 
had positive pleural fluid cultures: two due to Strepto- 
coccus veridas, one due to Streptococcus pneumoniae, 
one due to Klebsiella pneumoniae, and one due to 
Enterobacter species. Blood cultures were positive in 
only two patients: one due to S. veridans, and one due 
to S.pneumoniae. All patients in the UCPPE group had 
a pH value above 7.30, and all had sterile pleural fluids. 
Blood cultures were positive in two patients: one due to 
S. pneumoniae, and one due to K. pneumoniae. Values 
of pleural fluid glucose, LDH, pH, WBC, and neutrophils 
percentage are listed in Table 1. Tumor necrosis factor 
was detected in all serum and pleural fluid samples (Table 
2) and the groups did not show significant differences (JJ 
> 0.05). The mean values of TNFpf were 8.4 f 2.78 pg/mL 
(95% CI = 6.72-10.08) for UCPPE and 32.53 f 
Table 1. Values of Various Parameters in Patients with 
Uncomplicated, or Complicated Parapneumonic Effusion 
Group of Patients 
Parameter UCPPE (n = 13) CPPE (n = 8) 
Pleural fluid glucose (mg/dL) 108*25 33 * 8 
Lactate dehydrogenase (IU/L) 300+ 137 2012 + 948 
PH 7.42 + 0.04 6.87 f 0.13 
WBC (cells/mm3) 5242 zt 3719 24,862 + 10,283 
Neutrophils (%) 75.7 ZL 8.0 85.0 + 6.0 
UCPPE = uncomplicated parapneumonic effusion; CPPE = complicated 
parapneumonic effusion. 
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Table 2. Concentration Levels of Tumor Necrosis Factor in Serum and Pleural Fluid Samples of Patients 
with Uncomplicated, or Complicated Parapneumonic Effusion 
Group of Patients 
UCPPE (n = 13) 
Parameter Mean 5 SD 95% Cl 
Serum concentration (pg/mL)* 5.58 * 2.14 4.29- 6.87 
Pleural fluid concentration (pg/mL)+ 8.40 zk 2.78 6.72-l 0.08 
UCPPE = uncomplicated parapneumonic effusion; CPPE = complicated parapneumonic effusion. 
*P > 0.05; +P = 0.0008. 
CPPE (n = 8) 
Mean + SD 95% CI 
7.09 f 5.39 258-i 1.6 
3253 -?r 18.99 16.65-48.4 
18.99 pg/mL (95% CI = 16.65-48.4) for CPPE. Levels of 
TNF in pleural fluid were significantly higher in the CPPE 
group than in the UCPPE group (P = 0.0008) (Figure I), 
and TNFpf levels were significantly higher than TNFs lev- 
els in both groups (P < 0.001). The ratios of TNFpf to 
TNFs (TNFr) were 1.58 + 0.48 (95% CI = 1.29-1.87) for 
the UCPPE group and 5.23 + 2.13 (95% CI = 3.44-7.01 
for the CPPE group, significantly higher in the CPPE group 
than in the UCPPE group (P = 0.0002) (Figure 2). 
Since both TNFpf and TNFr were significantly higher 
in the CPPE group than in the UCPPE group, ROC analy- 
sis was used to detect the optimal cutoff point of both 
markers for better discrimination between UCPPE and 
CPPE groups. At an optimal cutoff point of 10.7 pg/mL 
for TNFpf, the sensitivity was 87.5% (95% CI = 65-100); 
the specificity was 92.3% (95% CI = 78-100); the positive 
predictive value (ppv> was 87.5% (95% CI = 64-100); the 
negative predictive value (NPV) was 93.3% (95% 
CI = 80-100); and the total accuracy was 90.5% (95% 
CI = 78-100) (P < 0.001). At an optimal cutoff point of 
3.0 for TNFr, the sensitivity, specificity, PPV NPV and total 
accuracy all were 100% (P < 0.00001). 
DISCUSSION 
The results of this study demonstrated that the levels of 
TNFpf and TNFr were significantly higher in the CPPE 
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group than in the UCPPE group; whereas no significant 
difference for TNFs was found between the two groups. 
This significant difference for TNFpf and TNFr between 
the two groups may, at least partly, be explained by the 
increased number of macrophages and neutrophils in 
CPPE in comparison with UCPPE.” In pleural effusions, 
macrophages, which are the main source of TNF pro- 
duction, are functionally active and can secrete TNF 
spontaneously and by interaction with bacteria and bac- 
terial cell walls.15-17 Stimulation of neutrophils, which 
are present in larger numbers in CPPEs than in UCPPEs, 
by infectious agents induces production and secretion of 
TNF by these cells. ‘*,19 The main decision to make in 
managing a patient with PPE is whether to insert a chest 
tube. Because a delay in instituting proper pleural 
drainage in such patients substantially increases mor- 
bidity, it is important to determine, as early as possible, 
whether a CPPE is present. There is no clinical problem, 
regarding insertion of a chest tube, in distinguishing 
between CPPE and empyema, because in both cases, 
insertion of a chest tube is indicated. The main problem 
is to distinguish between UCPPE and CPPE. For instance 
if the Gram stain or culture of the pleural fluid are pos- 
itive, tube thoracostomy is indicated regardless of the 
pH value.2 However, the diagnostic sensitivity of Gram 
stain of pleural effusion is low,’ and in cases where Gram 
stain and cultures of pleural fluid are negative, the deci- 
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sion to insert a chest tube depends mainly on the pH 
value, which is only valid when properly measured.2,8 
Furthermore, most reports describe a midrange of inde- 
terminate pleural fluid pH values, often placed between 
7.10 and 7.30, that do not reliably discriminate between 
CPPE and UCPPE.‘xs In those cases where the Gram stain 
and pleural fluid cultures are negative, and the pH value 
is in the indeterminate range TNFpf and particularly 
TNFr may be helpful in discriminating between UCPPE 
and CPPE. 
Indeed, absolute decision thresholds are needed for 
all patients with PPEs, irrespective of individual patient 
features that make a complicated effusion more or less 
likely.8 In this study a cutoff point of 3.0 for TNFr with 
a sensitivity and a specificity of 100% might be an 
absolute diagnostic threshold for discriminating between 
UCPPE and CPPE. However, this marker should be eval- 
uated in a larger population study before definitive con- 
clusions could be adopted. 
The high levels of TNFpf in the CPPE group in com- 
parison with those in the UCPPE group may represent 
more severe involvement of the pleura and the pleural 
cavity by the inflammatory and infectious processes in 
the CPPE group. Studies of TNF function found it to be 
at the head of the pro-inflammatory cytokine cascade 
and to have both beneficial and deleterious effects. This 
cytokine has been demonstrated to be a crucial factor in 
host defense against various microorganisms.20-22 Tumor 
necrosis factor is known to be important in inducing the 
acute-phase response that induces a wide range of phys- 
iologic changes beneficial in eliminating the infecting 
organism, limiting tissue damage, and activating the repair 
process.zo Furthermore, TNF potentiates the bactericidal 
properties of neutrophils,23 and it also upregulates vas- 
cular and neutrophil adhesion molecules, which facilitate 
neutrophil influx to the site of infection.20,24 On the other 
hand, severe excess of this potent pro-inflammatory 
cytokine, as in CPPEs, could be deleterious to the pleura 
and adjacent tissues, since severe excess of TNF may 
enhance the destructive processes in the inflamed and 
infected pleura, causing significant irreversible pleural 
damage.25 
CONCLUSION 
The results of this study indicate that TNFpf and, partic- 
ularly, TNFr are good markers for discrimination between 
UCPPE and CPPE. These markers may assist the decision 
for chest tube drainage in patients with PPE. However, fur- 
ther studies are needed in a larger population to confirm 
these findings. 
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